Mind + Muscle

technical minds + legal muscle

Bracket
Sterne Kessler Goldstein Fox
VideoPlay
Super Lawyers Jorge Goldstein
IAM 250

"The IAM Strategy 250 identifies individuals who offer world-class services related to the development and implementation of strategies which enable IP owners to maximise the value of their rights portfolios"

-Joff Wild, Editor, IAM Magazine

"A thought leader in the biotechnology area"

IAM Patent 1000 2015

"A real authority whose advice
is like gold dust."

 

Chambers 2013 icon

 

–Chambers USA
Jorge A. Goldstein, Ph.D.

Mind + Muscle

Jorge A. Goldstein, Ph.D.

Director

 

A Pioneer in Biotechnology Patent Law

Jorge is considered by his peers and clients to be one of the country’s pioneers in biotechnology patent law. He has almost forty years’ experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, organic synthesis, pharmaceuticals and polymers.

A founder of the Firm, Jorge is a Director in the firm's Biotechnology Practice Group. He chairs the Intellectual Property and Human Rights Pro Bono Practice. He has handled multiple and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He has also been involved in Inter Partes Reviews at the USPTO, as well as European oppositions, and arbitrations in District Court and in Appellate litigation both as counsel and expert witness, and in counseling clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements.

He has been named Extraordinary Professor of Law by the Universidad Austral in Buenos Aires, Argentina, where he teaches biotech patent law in the only WIPO-certified regional master's IP program in Latin America.

Dr. Goldstein's achievements include:
  • Leading Lawyer in Intellectual Property, Chambers USA, 2006-2015
  • Leading Lawyer in the Life Sciences, Chambers USA, 2007-2015
  • Best Lawyers' 2013 Washington DC Biotechnology Law 'Lawyer of the Year'
  • Judge for annual Law Practice Magazine EDGE Awards 2008-2009
  • Certified Licensing Professional 2014
  • Martindale Hubble Peer-Review Rating: AV
  • Order of the Coif, George Washington University Law School, 1982
  • Excellence in Teaching of Chemistry, Harvard University, 1972, 1974
  • Class of 1902 Research Prize, Rensselaer Polytechnic Institute, 1971
Recent Publications
  • "Of Isolated Genes and Covalent Bonds: A Personal Memoir of Myriad Genetics," Jorge A. Goldstein, Ph.D., Intellectual Property Today, April 2015.
  • "Sobre Genes Aislados y Enlaces Covalentes: Un Recuerdo Personal de Myriad Genetics," Jorge A. Goldstein, Ph.D. Revista Iberoamericana de la Propiedad Intelectual, June 2015.
  • "Patenting Purified Natural Products by Specific Activity: Eligibility and Enablement," Jorge A. Goldstein, Ph.D. and Chenghua Luo, Ph.D., Bloomberg BNA Life Sciences Law and Industry Report, May 2015.
  • "AbbVie Deutschland and Unknown Embodiments: Has the Written Description Requirements for Antibodies Gone Too Far?" Jorge A. Goldstein, Ph.D., Bloomberg BNA Life Science Law & Industry Report, April 2015 (Reproduced in 
    BNA Patent, Trademark & Copyright Journal, May 2015).
  • "Personalized Medicine Patents in Great Legal Turmoil," Jorge A. Goldstein, Ph.D. and Cynthia M. Bouchez, Intellectual Property Today, August 2011.
  • Representative Matters
      Dr. Goldstein's achievements include:
      • Leading Lawyer in Intellectual Property, Chambers USA, 2006-2015
      • Leading Lawyer in the Life Sciences, Chambers USA, 2007-2015
      • Best Lawyers' 2013 Washington DC Biotechnology Law 'Lawyer of the Year'
      • Judge for annual Law Practice Magazine EDGE Awards 2008-2009
      • Certified Licensing Professional 2014
      • Martindale Hubble Peer-Review Rating: AV
      • Order of the Coif, George Washington University Law School, 1982
      • Excellence in Teaching of Chemistry, Harvard University, 1972, 1974
      • Class of 1902 Research Prize, Rensselaer Polytechnic Institute, 1971
      Recent Publications
      • "Of Isolated Genes and Covalent Bonds: A Personal Memoir of Myriad Genetics," Jorge A. Goldstein, Ph.D., Intellectual Property Today, April 2015.
      • "Sobre Genes Aislados y Enlaces Covalentes: Un Recuerdo Personal de Myriad Genetics," Jorge A. Goldstein, Ph.D. Revista Iberoamericana de la Propiedad Intelectual, June 2015.
      • "Patenting Purified Natural Products by Specific Activity: Eligibility and Enablement," Jorge A. Goldstein, Ph.D. and Chenghua Luo, Ph.D., Bloomberg BNA Life Sciences Law and Industry Report, May 2015.
      • "AbbVie Deutschland and Unknown Embodiments: Has the Written Description Requirements for Antibodies Gone Too Far?" Jorge A. Goldstein, Ph.D., Bloomberg BNA Life Science Law & Industry Report, April 2015 (Reproduced in 
        BNA Patent, Trademark & Copyright Journal, May 2015).
      • "Personalized Medicine Patents in Great Legal Turmoil," Jorge A. Goldstein, Ph.D. and Cynthia M. Bouchez, Intellectual Property Today, August 2011.
  • Admissions
      • District of Columbia

      • United States Patent and Trademark Office

      • Court of Appeals for the Federal Circuit

  • Education
    • J.D., The George Washington University with high honors

    • Ph.D., Chemistry, Harvard University

    • B.S., Chemistry, Rensselaer Polytechnic Institute

    X

    Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.